FDA.reportPublic FDA data

Trilipix 135 MG Delayed Release Oral Capsule

RxCUI
828377
RxNorm name
Trilipix 135 MG Delayed Release Oral Capsule
Display name
Trilipix 135 MG Delayed Release Oral Capsule
Full name
Trilipix 135 MG Delayed Release Oral Capsule
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
3057fc9c-ff77-43eb-b687-776660423742Trilipix 135 MG Delayed Release Oral CapsuleSY1These highlights do not include all the information needed to use Trilipix safely and effectively. See full prescribing information for Trilipix. Trilipix (fenofibric acid) capsule, delayed release for oral use Initial U.S. Approval: 200820111214
3057fc9c-ff77-43eb-b687-776660423742fenofibric acid 135 MG Delayed Release Oral Capsule [Trilipix]SBD1These highlights do not include all the information needed to use Trilipix safely and effectively. See full prescribing information for Trilipix. Trilipix (fenofibric acid) capsule, delayed release for oral use Initial U.S. Approval: 200820111214
3057fc9c-ff77-43eb-b687-776660423742Trilipix 135 MG Delayed Release Oral CapsulePSN1These highlights do not include all the information needed to use Trilipix safely and effectively. See full prescribing information for Trilipix. Trilipix (fenofibric acid) capsule, delayed release for oral use Initial U.S. Approval: 200820111214